LHC Group Concludes Strategic Review Process; Board of Directors Affirms Business Strategy, Continued Stock Repurchase

The Board of Directors of LHC Group Inc. LHCG has reaffirmed the Company's commitment to maximizing shareholder value as an independent public corporation, concluding the Company's previously announced review of strategic alternatives. The review process commenced in November 2011 and involved an objective review of all strategic alternatives for the Company, including execution of the Company's operating plan for 2012 through 2016. Following this comprehensive review process, the Company's Board of Directors unanimously concluded that the continued execution of the Company's operating plan, supplemented by its share repurchase program, provides the best opportunity to enhance value for the Company's shareholders. The Company's Board of Directors also authorized the continuation of a stock repurchase program under which the Company may repurchase up to $50 million of LHC Group's outstanding common stock. The stock repurchase program does not obligate the company to acquire a minimum amount of common stock and may be modified, suspended, terminated or extended by the company at any time without prior notice. Repurchases under the stock repurchase program would be funded from available cash or borrowings under existing or new debt facilities.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsBuybacksHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!